LONDON (Alliance News) – British polymer technology company, Revolymer PLC, said Monday that it has signed a supply and distribution deal for its nicotine chewing gum products in the United States with PL Developments LLC, a US manufacturer and supplier of over-the-counter products.
Revolymer said that under the terms of the agreement, PL Developments will be responsible for marketing, sales and distribution of its nicotine gum products within this territory.
The polymer firm said its nicotine chewing gum products offer a number of consumer benefits in comparison to currently marketed nicotine gum including a more confectionery-like chew and faster release of nicotine. The US company plans to market and sell private label formats of Revolymer’s nicotine chewing gum products to its broad customer base including all major mass merchandiser, drug, food, dollar channel, and club store retailers.
The AIM-listed company Monday said that the agreement is subject to regulatory approval of Revolymer’s products and the preparation of an application for marketing approval is currently under discussion with the FDA.
“The team at PLD is very experienced at packaging and distributing OTC pharmaceutical products and consumer healthcare goods nationally across America to major grocery, mass merchandiser, and pharmacy chains, and we look forward to a mutually fruitful relationship going forward. We are now focused on preparing a regulatory dossier with view to filing for and gaining marketing approval for our nicotine gum products in the US,” said Robin Cridland, Acting CEO of Revolymer.
According to market estimates agreed between PLD and Revolymer, the US nicotine gum market has a current retail value of nearly USD500 million per annum, of which more than half is private label, and the balance branded products.
